Pfizer Wins Challenge to Norvasc Patent by Mylan Laboratories NEW YORK, Feb. 27 -- Pfizer Inc said today that a federal court in the Western District of Pennsylvania (Pittsburgh) has upheld the ...

NEW YORK, Feb 1 (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ...

Mylan Laboratories said on Monday it agreed to acquire troubled drugmaker King Pharmaceuticals Inc. for about $4 billion, adding patent-protected brand drugs to Mylan’s generic-drug offerings.

PITTSBURGH, Pa.--(BUSINESS WIRE)--April 10, 2003--Mylan Laboratories Inc. (NYSE: MYL) a leading developer, manufacturer and marketer of generic and proprietary pharmaceuticals announced today the ...

GARY E. SPHAR is Vice President-Corporate Controller of Mylan Laboratories Inc. Mr. Sphar is responsible for accounting policies and functions, internal and external financial reporting, budgeting, ...

PITTSBURGH, Sept. 15 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. today announced the nomination of Neil Dimick to the Mylan Board of Directors. Mr. Dimick, 56 ...

(Reuters) - The U.S. Supreme Court on Tuesday turned back challenges by Apple Inc and drugmaker Mylan Laboratories Ltd to a rule change that made it harder to contest patents before the U.S. Patent ...

BERLIN — German drug maker Merck KGaA announced Sunday that it is selling its generic drug business to Mylan Laboratories Inc. of the U.S. for $6.6 billion. The deal frees Darmstadt-based Merck to ...

NEW YORK (MarketWatch) -- Mylan Laboratories Inc. said it inked a deal to allow Cephalon Inc. to use its transdermal technology in two separate agreements aimed at treatments for pain and nervous ...

NEW DELHI (MarketWatch) -- U.S.-based Mylan Laboratories Inc. MYL plans to acquire an additional 24% stake in India's Matrix Laboratories Ltd. (524794.BY) through an open offer, the Mint newspaper ...